News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,501 Results
Type
Article (5044)
Company Profile (30)
Press Release (166427)
Section
Business (49737)
Career Advice (233)
Deals (12540)
Drug Delivery (5)
Drug Development (11569)
Employer Resources (12)
FDA (4290)
Job Trends (3382)
News (79740)
Policy (6250)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (437)
Allergies (9)
Alliances (15867)
ALS (10)
Alzheimer's disease (401)
Antibody-drug conjugate (ADC) (4)
Approvals (4302)
Artificial intelligence (80)
Automation (5)
Bankruptcy (117)
Best Places to Work (2884)
Biosimilars (13)
Biotechnology (18)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (66)
Cancer (490)
Cardiovascular disease (25)
Career advice (205)
Career pathing (1)
CAR-T (14)
Cell therapy (41)
Cervical cancer (4)
Clinical research (9331)
Collaboration (185)
Compensation (30)
COVID-19 (524)
C-suite (36)
Cystic fibrosis (18)
Data (341)
Decentralized trials (1)
Depression (7)
Diabetes (28)
Diagnostics (5862)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (17)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (16743)
Employer branding (2)
Employer resources (12)
Events (22552)
Executive appointments (157)
FDA (4524)
Featured Employer (7)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (168)
Gene editing (3)
Generative AI (8)
Gene therapy (18)
GLP-1 (60)
Government (748)
Guidances (7)
Healthcare (4603)
IgA nephropathy (1)
Immunology and inflammation (7)
Indications (3)
Infectious disease (554)
Inflammatory bowel disease (25)
Influenza (12)
Intellectual property (11)
Interviews (35)
IPO (6216)
IRA (1)
Job creations (580)
Job search strategy (183)
Kidney cancer (4)
Labor market (1)
Layoffs (31)
Leadership (1)
Legal (1371)
Liver cancer (14)
Lung cancer (62)
Lymphoma (34)
Management (3)
Manufacturing (49)
MASH (9)
Medical device (3974)
Medtech (3974)
Mergers & acquisitions (6572)
Metabolic disorders (60)
Multiple sclerosis (17)
NASH (4)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (481)
NextGen: Class of 2025 (1513)
Non-profit (689)
Northern California (482)
Now hiring (2)
Obesity (24)
Opinion (12)
Ovarian cancer (15)
Pain (12)
Pancreatic cancer (20)
Parkinson's disease (24)
Partnered (6)
Patents (35)
Patient recruitment (16)
Peanut (4)
People (14377)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase I (2853)
Phase II (4132)
Phase III (3280)
Pipeline (165)
Podcasts (1)
Policy (2)
Postmarket research (335)
Preclinical (1197)
Press Release (12)
Prostate cancer (33)
Psychedelics (2)
Radiopharmaceuticals (141)
Rare diseases (51)
Real estate (1307)
Recruiting (6)
Regulatory (4529)
Reports (12)
Research institute (536)
Resumes & cover letters (30)
RSV (1)
Schizophrenia (8)
Series A (17)
Series B (15)
Service/supplier (2)
Sickle cell disease (9)
Southern California (464)
Sponsored (5)
Startups (1009)
State (1)
Stomach cancer (2)
Supply chain (7)
The Weekly (1)
United States (4980)
Vaccines (52)
Venture capitalists (5)
Webinars (1)
Weight loss (6)
Women's health (5)
Date
Today (43)
Last 7 days (181)
Last 30 days (811)
Last 365 days (8832)
2025 (1510)
2024 (8977)
2023 (10875)
2022 (15706)
2021 (16285)
2020 (15425)
2019 (10852)
2018 (8464)
2017 (8754)
2016 (8106)
2015 (9905)
2014 (7239)
2013 (6273)
2012 (6693)
2011 (6640)
2010 (5898)
Location
Africa (146)
Alabama (8)
Alaska (1)
Arizona (70)
Arkansas (3)
Asia (8419)
Australia (1567)
California (1183)
Canada (361)
China (48)
Colorado (60)
Connecticut (91)
Delaware (14)
Europe (19403)
Florida (197)
Georgia (54)
Idaho (11)
Illinois (128)
India (4)
Indiana (74)
Iowa (3)
Japan (25)
Kansas (29)
Kentucky (5)
Louisiana (1)
Maine (53)
Maryland (155)
Massachusetts (723)
Michigan (114)
Minnesota (100)
Mississippi (2)
Missouri (26)
Montana (6)
Nebraska (10)
Nevada (23)
New Hampshire (25)
New Jersey (349)
New Mexico (18)
New York (438)
North Carolina (315)
North Dakota (6)
Northern California (482)
Ohio (46)
Oklahoma (2)
Oregon (7)
Pennsylvania (223)
Rhode Island (4)
South America (208)
South Carolina (7)
Southern California (464)
Tennessee (41)
Texas (257)
Utah (90)
Virginia (37)
Washington D.C. (6)
Washington State (101)
West Virginia (1)
Wisconsin (30)
171,501 Results for "sekisui diagnostics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in professional and home testing settings.
March 5, 2024
·
2 min read
Press Releases
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
November 15, 2024
·
2 min read
Business
SEKISUI Diagnostics and Aptitude Partner to Provide Metrix™ COVID-19 Tests to the Point-of-Care and Home Test Markets
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has formalized an exclusive distribution agreement with Aptitude Medical Systems (Aptitude™), an innovative developer of decentralized molecular diagnostics, to sell the Aptitude Metrix™ COVID-19 Test in the U.S.
January 3, 2024
·
3 min read
Genetown
SEKISUI Diagnostics announces the Launch of the OSOM® COVID-19 Antigen Home Test
SEKISUI Diagnostics announces the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
July 31, 2023
·
2 min read
Press Releases
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
December 19, 2024
·
4 min read
Business
Diagnostics Direct, LLC Announces Formation of a Medical Advisory Board
Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.
March 13, 2024
·
3 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
BioMidwest
C₂N Diagnostics, LLC Announces Investment From Eisai Inc.
C₂N Diagnostics, LLC, a leader in advanced brain health diagnostics, and Eisai Inc., a “human health care company,” have announced Eisai has made an investment of up to 15 million USD in C₂N.
March 6, 2024
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
1 of 17,151
Next
